Search Within

Sujata Patil

  1. "Annals of Oncology"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (3)
Groups
  1. Biostatistics Service (9)
  2. Department of Medicine (9)
  3. Epidemiology and Biostatistics (9)
  4. Solid Tumor Oncology Division (9)
  5. Breast Medicine Service (7)
  6. Survivorship Research (6)

More Groups

People
  1. Clifford Hudis (6)
  2. Larry Norton (3)
  3. Tiffany Traina (3)
  4. Ayca Gucalp (2)
  5. Edi Brogi (2)
  6. Heather Mcarthur (2)

More People

Years
  1. 2019 (1)
  2. 2016 (2)
  3. 2014 (1)
  4. 2012 (1)
  5. 2011 (2)
  6. 2009 (2)
Publications
  1. Annals of Oncology (9)
Publishers
  1. Oxford University Press (9)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard care in women with residual, early stage/resectable, triple negative breast cancer after standard-of-care neoadjuvant chemotherapy
    Meeting Abstract

    McArthur, H. L.; Comen, E. A.; Bryce, Y.; Solomon, S. B.; Leal, J. H. S.; Rodine, M.; Abaya, C. D.; Patil, S.; Page, D. B.; Norton, L.
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Phase Ib/II open-label study of Ad-RTS-hIL-12 + veledimex gene therapy in chemotherapy-responsive locally advanced or metastatic breast cancer patients
    Meeting Abstract

    McArthur, H.; Page, D.; Proverbs-Singh, T.; Solomon, S.; Hudis, C.; Norton, L.; Patil, S.; Henrich, M.; Halpenny, D.; Erinjeri, J.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Phase I/II trial of palbociclib in combination with bicalutamide for the treatment of androgen receptor (AR)(+) metastatic breast cancer (MBC): Pharmacokinetics (PK)
    Meeting Abstract

    Gucalp, A.; Corben, A.; Patil, S.; Boyle, L. A.; Hudis, C.; Traina, T. A.
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies
    Journal Article

    Voss, M. H.; Bastos, D. A.; Karlo, C. A.; Ajeti, A.; Hakimi, A. A.; Feldman, D. R.; Hsieh, J. J.; Molina, A. M.; Patil, S.; Motzer, R. J.
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • EGFR and P53 expression in androgen receptor (AR)-positive, triple negative breast cancer (TNBC)
    Meeting Abstract

    Gucalp, A.; Gupta, G.; Patil, S.; Wen, Y. H.; Akram, M.; Brogi, E.; Powell, S.; Ho, A.; Hudis, C. A.; Traina, T. A.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Breast carcinoma with brain metastases: Clinical analysis and immunoprofile on tissue microarrays
    Journal Article

    Brogi, E.; Murphy, C. G.; Johnson, M. L.; Conlin, A. K.; Hsu, M.; Patil, S.; Akram, M.; Nehhozina, T.; Jhaveri, K. L.; Hudis, C. A.; more...
    Annals of Oncology (2011)

    Fulltext@MSK | Save
  • Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma
    Journal Article

    Patil, S.; Figlin, R. A.; Hutson, T. E.; Michaelson, M. D.; Negrier, S.; Kim, S. T.; Huang, X.; Motzer, R. J.
    Annals of Oncology (2011)

    Fulltext@MSK | Save
  • Androgen receptor inhibition can stabilize disease in patients with AR(+), ER(-)/PR(-) metastatic breast cancer
    Meeting Abstract

    Traina, T. A.; Feigin, K.; Patil, S.; Yuan, J.; Dickler, M.; Andrea, G. D.; Bromberg, J.; Hudis, C.
    Annals of Oncology (2009)

    Fulltext@MSK | Save
  • TOPO2A and HER2 co-amplification is uncommon by high resolution representational oligonucleotide microarray analysis (ROMA) in human breast cancer
    Meeting Abstract

    Hicks, J.; Mcarthur, H.; Tan, L. K.; Patil, S.; Wigler, M.; Hudis, C.; Norton, L.
    Annals of Oncology (2009)

    Fulltext@MSK | Save